Assessment Regarding Primary Preventive Screening of Atrial Fibrillation with Thumb ECG

The Swedish Dental and Pharmaceutical Benefits Agency (TLV) has been commissioned by the Government to conduct health technology assessments of medical devices in an early stage of the product life cycle.

TLV has performed an economic evaluation of the method primary preventive screening of atrial fibrillation with thumb ECG.

Thumb ECG is a mobile device for ECG recordings and TLV concludes that the use of the method is reasonably cost-effective according to available data.